Alterity Therapeutics (ATHE) Income from Non-Controlling Interests (2016 - 2019)
Alterity Therapeutics' (ATHE) quarterly Income from Non-Controlling Interests came in at -$3.9 million in Q4 2019, down 0.58% year-on-year from -$3.9 million in Q4 2018, and down 0.58% quarter-over-quarter from -$3.8 million in Q4 2018.
Alterity Therapeutics (ATHE) Income from Non-Controlling Interests (2016 - 2019) Analysis & Trends
Alterity Therapeutics' Income from Non-Controlling Interests history runs 4 years deep, the most recent figure standing at -$3.9 million for Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -3.85 Mn |
| Dec 31, 2018 | -3.83 Mn |
| Dec 31, 2017 | -2.78 Mn |
| Dec 31, 2016 | -2.74 Mn |